| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | China | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Republic of Korea | 3 | |
| #5 | WIPO (World Intellectual Property Organization) | 3 | |
| #6 | Australia | 2 | |
| #7 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Organic chemistry methods |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wu Jiaquan | 18 |
| #2 | Jin Shenshuang | 12 |
| #3 | Li Li | 8 |
| #4 | Dong Jian | 8 |
| #5 | Zhang Shuai | 8 |
| #6 | Zhou Ping | 8 |
| #7 | Lu Zhenghua | 7 |
| #8 | Tan Qiu | 7 |
| #9 | Wang Chengchen | 7 |
| #10 | Cao Huanyan | 6 |
| Publication | Filing date | Title |
|---|---|---|
| US2020339572A1 | Novel selective cdk4/6 inhibitor and preparation thereof | |
| WO2019178868A1 | Pharmaceutical composition and preparation method therefor and uses thereof | |
| CN107176954A | Pharmaceutical salts and its crystal formation, the preparation method and application of a kind of EGFR inhibitor | |
| EP3345906A1 | 2-arylamino pyridine, pyridine or triazine derivative, preparation method and use thereof |